| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
CAH
Cardinal Health
|
Aug 03, 2026 | HOLD |
Strong Buy
-17.4% avg upside
29 analysts
|
— | +1.5% | · |
|
UNH
UnitedHealth
|
Aug 03, 2026 | HOLD |
Strong Buy
+10.6% avg upside
36 analysts
|
— | -1.9% | · |
|
CI
Cigna
|
Aug 03, 2026 | HOLD |
Strong Buy
+28.1% avg upside
29 analysts
|
$305.00
12.84% Upside
|
+0.0% | · |
|
WAY
Waystar Holding Corp.
|
Jul 31, 2026 | BUY |
Strong Buy
+58.8% avg upside
30 analysts
|
$39.00
66.74% Upside
|
+10.8% | · |
|
HUM
Humana
|
Jul 30, 2026 | BUY |
Buy
+14.9% avg upside
34 analysts
|
$436.00
19.83% Upside
|
-0.3% | · |
|
CNC
Centene
|
May 20, 2026 | BUY |
Buy
+7.0% avg upside
29 analysts
|
$80.00
19.42% Upside
|
+8.7% | · |
|
ELV
Elevance Health
|
May 20, 2026 | BUY |
Strong Buy
+15.8% avg upside
33 analysts
|
$498.00
27.32% Upside
|
-0.9% | · |
|
MCK
McKesson
|
May 08, 2026 | BUY |
Strong Buy
-16.6% avg upside
28 analysts
|
$875.00
0.27% Downside
|
+19.3% | · |
|
EHTH
Ehealth
|
May 08, 2026 | HOLD |
Hold
+1148.5% avg upside
19 analysts
|
$3.00
138.16% Upside
|
-30.2% | · |
|
CVS
CVS Health
|
May 07, 2026 | BUY |
Strong Buy
+5.1% avg upside
39 analysts
|
$92.00
7.10% Downside
|
+20.3% | · |
|
AGL
Agilon Health
|
May 07, 2026 | BUY |
Hold
-52.6% avg upside
26 analysts
|
$49.00
54.55% Downside
|
+77.8% | · |
|
HIMS
Hims & Hers Health
|
May 05, 2026 | HOLD |
Buy
-15.4% avg upside
22 analysts
|
$25.00
21.05% Downside
|
+22.3% | · |
|
MOH
Molina Healthcare
|
Apr 24, 2026 | HOLD |
Buy
+22.0% avg upside
26 analysts
|
$129.00
33.94% Downside
|
+10.9% | · |
|
HQY
Healthequity
|
Mar 19, 2026 | BUY |
Strong Buy
+9.2% avg upside
20 analysts
|
$128.00
22.63% Upside
|
+28.6% | · |
|
TDOC
Teladoc
|
Mar 10, 2026 | BUY |
Buy
+318.2% avg upside
38 analysts
|
$11.00
58.64% Upside
|
+20.5% | · |
|
DH
Definitive Healthcare Corp
|
Feb 27, 2026 | HOLD |
Hold
+734.6% avg upside
19 analysts
|
$3.00
349.41% Upside
|
-46.7% | · |
|
GDRX
GoodRx Holdings
|
Feb 27, 2026 | HOLD |
Buy
+297.5% avg upside
28 analysts
|
$3.00
8.16% Downside
|
+64.2% | · |
|
COR
Cencora
|
Nov 07, 2025 | BUY |
Buy
-1.3% avg upside
44 analysts
|
$371.00
16.97% Upside
|
-13.4% | · |
|
ICLR
Icon
|
Jul 29, 2025 | BUY |
Strong Buy
+15.9% avg upside
26 analysts
|
$210.00
28.50% Upside
|
-3.8% | · |
|
MDRX
Veradigm
|
Mar 27, 2025 | HOLD |
Buy
+207.0% avg upside
22 analysts
|
$5.00
4.10% Upside
|
+13.1% | · |
|
ABBV
AbbVie
|
Jun 28, 2024 | HOLD |
Strong Buy
-3.2% avg upside
46 analysts
|
$175.00
28.92% Downside
|
+10.2% | · |
|
IQV
IQVIA Holdings
|
Mar 22, 2022 | BUY |
Strong Buy
+2.9% avg upside
39 analysts
|
$250.00
5.88% Upside
|
-17.0% | · |
|
CRL
Charles River Labs
|
Feb 16, 2022 | BUY |
Strong Buy
-13.9% avg upside
34 analysts
|
$350.00
34.21% Upside
|
-16.7% | · |
|
KRC
Kilroy Realty
|
May 06, 2020 | HOLD |
Buy
+18.3% avg upside
26 analysts
|
$68.00
75.92% Upside
|
+18.6% | · |
|
HSIC
Henry Schein
|
Sep 19, 2017 | HOLD |
Buy
+0.9% avg upside
25 analysts
|
$91.00
1.55% Upside
|
+6.8% | · |
|
C
Citigroup
|
Oct 06, 2011 | BUY |
Strong Buy
-13.5% avg upside
37 analysts
|
— | +33.8% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.